These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
298 related items for PubMed ID: 4994940
1. [Survival of tuberculous bacilli in combined treatments including rifampicin]. Kreis B, Pretet S. Rev Tuberc Pneumol (Paris); 1970; 34(3):429-33. PubMed ID: 4994940 [No Abstract] [Full Text] [Related]
3. Primary and acquired drug resistance in Mycobacterium tuberculosis strains in western region of Libyan Arab Jamahiriya. Elghoul MT, Joshi RM, Rizghalla T. Trop Geogr Med; 1989 Oct; 41(4):304-8. PubMed ID: 2517554 [Abstract] [Full Text] [Related]
4. [Experimental in-vitro and in-vivo studies of the antibacterial effect of rifampicin and ethambutol]. Kozulicyna TI, Korotajev GA. G Ital Chemioter; 1972 Oct; 19(2):7-10. PubMed ID: 4199030 [No Abstract] [Full Text] [Related]
8. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002). Negi SS, Gupta S, Lal S. J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952 [Abstract] [Full Text] [Related]
9. Correlation of in vitro and in vivo kinetics with clinical use of isoniazid, ethambutol, and rifampin. Jenne JW, Beggs WH. Am Rev Respir Dis; 1973 Jun; 107(6):1013-21. PubMed ID: 4197230 [No Abstract] [Full Text] [Related]
11. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin). Pines A, Raafat H, Siddiqui GM. J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340 [No Abstract] [Full Text] [Related]
12. [Question of bactericidal effect of a combination of maximally tolerable doses of INH, Myambutol and Rifadin on experimental tuberculosis]. Djurisić M, Davidović C, Leposavić M, Jovancvić M, Marković L, Popović S. Plucne Bolesti Tuberk; 1973 Mar; 25(3):251-6. PubMed ID: 4210992 [No Abstract] [Full Text] [Related]
13. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia. Toungoussova S, Caugant DA, Sandven P, Mariandyshev AO, Bjune G. Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916 [Abstract] [Full Text] [Related]
15. A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987. Jalleh RD, Kuppusamy I, Soshila R, Aziah AM, Faridza MY. Med J Malaysia; 1993 Jun; 48(2):113-6. PubMed ID: 8350784 [Abstract] [Full Text] [Related]
18. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. VII. September 1965 to September 1969. Hobby GL, Johnson PM, Boytar-Papirnyik V. Am Rev Respir Dis; 1970 Sep; 102(3):347-55. PubMed ID: 4989604 [No Abstract] [Full Text] [Related]
19. Sensitivity to Ethambutol and Rifampicin of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka. Pinto MR, Arseculeratne SN, Dasan P, Uragoda CG. Ceylon Med J; 1982 Jun; 27(2):75-9. PubMed ID: 6819093 [No Abstract] [Full Text] [Related]
20. [Sensitivity to rifampicin and ethambutol of mycobacteria resistant to isoniazid or streptomycin]. Golychevskaja VI. G Ital Chemioter; 1972 Jun; 19(2):20-2. PubMed ID: 4199029 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]